Manulife (Manufacturers Life Insurance)’s Aquestive Therapeutics AQST Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$122K	Buy	29,270 +1,348	+5%	+$5.67K	﹤0.01%	2702
2026 Q1	$116K	Sell	27,922 -3,813	-12%	-$15.5K	﹤0.01%	2592
2025 Q4	$205K	Buy	31,735 +1,829	+6%	+$11.4K	﹤0.01%	2517
2025 Q3	$167K	Sell	29,906 -2,167	-7%	-$9.37K	﹤0.01%	2641
2025 Q2	$106K	Buy	32,073 +4,557	+17%	+$13.1K	﹤0.01%	2743
2025 Q1	$79.8K	Buy	27,516 +288	+1%	+$872	﹤0.01%	2745
2024 Q4	$96.9K	Sell	27,228 -813	-3%	-$3.75K	﹤0.01%	2821
2024 Q3	$140K	Sell	28,041 -1,330	-5%	-$5.18K	﹤0.01%	2774
2024 Q2	$76.4K	Buy	+29,371	New	+$98.1K	﹤0.01%	2892
2021 Q1	–	Sell	-11,338	Closed	-$61K	–	3076
2020 Q4	$61K	Sell	11,338 -1,535	-12%	-$9.2K	﹤0.01%	2973
2020 Q3	$62K	Buy	+12,873	New	+$84.1K	﹤0.01%	2882

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AQST Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Aquestive Therapeutics (AQST) stake by 4.8% in Q2 2026, buying an estimated $5.67K and bringing the position to 29,270 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #2702.

Manulife (Manufacturers Life Insurance) first reported a position in AQST in Q3 2020 and has held it in 11 quarters since. The position peaked at $205K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

Manulife (Manufacturers Life Insurance) held 29,270 shares of Aquestive Therapeutics worth $122K as of Q2 2026.
Manulife (Manufacturers Life Insurance) bought 1,348 Aquestive Therapeutics shares in Q2 2026, an estimated $5.67K.
Aquestive Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2702 holding.
Manulife (Manufacturers Life Insurance) first reported a position in Aquestive Therapeutics in Q3 2020 and has held it in 11 quarters since.
Manulife (Manufacturers Life Insurance)'s Aquestive Therapeutics position peaked at $205K in Q4 2025.
184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.